New insight into old IBD drug could improve treatments

Weill Cornell researchers find inflammatory bowel disease drug works by modulating the activity of a group of gut bacteria that are more abundant in patients who respond to the drug.

Related Keywords

United States ,Americans ,Randy Longman ,Longman ,Jill Roberts Center ,Jill Roberts Institute For Research ,Presbyterian Weill Cornell Medical Center ,Jill Roberts Institute ,Weill Cornell Medicine ,Cell Reports Medicine ,Weill Cornell Medical ,Svetlana Lima ,Silvia Pires ,